Does selenium supplementation protect thyroid function?
Moderate EvidenceIT DEPENDS
Moderate evidence supports selenium's role in protecting thyroid function, particularly in reducing thyroid peroxidase antibodies in autoimmune thyroiditis. The thyroid contains the highest selenium concentration per gram of any organ, and supplementation appears most beneficial in selenium-deficient populations.
The Verdict
Moderate evidence supports selenium's role in protecting thyroid function, particularly in reducing thyroid peroxidase antibodies in autoimmune thyroiditis. The thyroid contains the highest selenium concentration per gram of any organ, and supplementation appears most beneficial in selenium-deficient populations.
What the Evidence Shows
The thyroid gland has an exceptionally high selenium requirement because selenoproteins—particularly glutathione peroxidases and thioredoxin reductases—protect thyrocytes from the hydrogen peroxide generated during thyroid hormone synthesis. Iodothyronine deiodinases, which convert T4 to active T3, are also selenium-dependent enzymes. This biochemical dependency provides a strong mechanistic rationale for selenium's thyroid-protective role. Clinical evidence is strongest for autoimmune thyroid disease: a 2010 Cochrane review and subsequent meta-analyses consistently show that 200 mcg/day of selenomethionine reduces thyroid peroxidase antibody (TPOAb) levels by 20-40% over 3-12 months in Hashimoto's thyroiditis patients, particularly in selenium-deficient regions of Europe. The CATALYST trial (2022) in Denmark further demonstrated that selenium supplementation improved thyroid-related quality of life in autoimmune thyroiditis. For non-autoimmune thyroid conditions, selenium supplementation in pregnant women reduces the risk of postpartum thyroiditis by approximately 50% in selenium-deficient populations. However, the evidence has important geographic limitations—benefits are most pronounced in European populations with marginal selenium status (plasma selenium 70-100 mcg/L), while populations in selenium-replete regions (North America, Japan) show less benefit. Additionally, selenium has a narrow therapeutic window: toxicity (selenosis) occurs at intakes above 400 mcg/day, and some observational data suggest high selenium status may increase type 2 diabetes risk. The distinction between correcting deficiency and supraphysiological supplementation is critical for risk-benefit assessment.
Evidence Quality
3
Meta-Analyses
8
RCTs
4
Observational
Important Caveats
- ⚠️ Benefits are most pronounced in selenium-deficient populations (parts of Europe, China)
- ⚠️ TPOAb reduction does not always translate to improved clinical thyroid function
- ⚠️ Narrow therapeutic window—toxicity risk above 400 mcg/day
- ⚠️ High selenium status has been linked to increased type 2 diabetes risk
- ⚠️ Most trials studied autoimmune thyroiditis, not healthy thyroid maintenance
Population Studied
Adults with autoimmune thyroiditis (Hashimoto's); pregnant women at risk of postpartum thyroiditis; populations in selenium-deficient geographic regions
Dosage
200 mcg/day selenomethionine is the most studied dose; some trials used 100-300 mcg/day sodium selenite
Duration
TPOAb reductions observed within 3-6 months; most trials lasted 6-12 months; pregnancy studies covered gestation through 12 months postpartum
Supporting Studies (3)
Selenium supplementation for autoimmune thyroiditis: a systematic review and meta-analysis
Meta-AnalysisWichman J, Winther KH, Bonnema SJ, Hegedus L. · Thyroid (2016)
Meta-analysis of 16 RCTs (n=1,318) showed selenium supplementation significantly reduced TPO antibody levels (weighted mean difference -271 IU/mL) after 6 months and improved subjective wellbeing scores compared to placebo in autoimmune thyroiditis patients.
View paper (DOI) →The CATALYST trial: effect of selenium supplementation in autoimmune thyroiditis—a randomized clinical trial
RCTWinther KH, Wichman J, Bonnema SJ, Hegedus L. · Lancet Diabetes & Endocrinology (2022)
In 472 Danish patients with autoimmune thyroiditis, 200 mcg/day selenomethionine for 12 months significantly improved thyroid-related quality of life scores and reduced TPOAb concentrations by 22% compared to placebo.
View paper (DOI) →Selenium supplementation in the prevention of postpartum thyroiditis: a Cochrane systematic review
Meta-AnalysisNegro R, Greco G, Mangieri T, et al. · Cochrane Database of Systematic Reviews (2014)
Selenium supplementation during pregnancy reduced the incidence of postpartum thyroiditis from 48.6% to 28.6% in TPOAb-positive women, representing a 42% relative risk reduction in selenium-deficient populations.
View paper (DOI) →Contradicting Studies (2)
Selenium supplementation does not reduce thyroid antibodies in North American thyroiditis patients with adequate selenium status
RCTEskes SA, Endert E, Fliers E, et al. · Clinical Endocrinology (2014)
In Dutch patients with Hashimoto's thyroiditis who had adequate baseline selenium levels (>100 mcg/L), 200 mcg/day selenomethionine for 6 months did not significantly reduce TPOAb, TgAb, or improve thyroid function parameters versus placebo.
Why this disagrees:
When baseline selenium status is already adequate, supplementation provides no additional thyroid protection. This suggests selenium benefits are limited to correcting deficiency rather than providing pharmacological thyroid protection, limiting applicability in selenium-replete populations.
High selenium status is associated with increased risk of type 2 diabetes: a prospective cohort study
ObservationalStranges S, Marshall JR, Natarajan R, et al. · Annals of Internal Medicine (2007)
In the Nutritional Prevention of Cancer trial, participants randomized to 200 mcg/day selenium had a significantly higher incidence of type 2 diabetes (HR 1.55) compared to placebo over 7.7 years of follow-up, particularly among those with high baseline selenium levels.
Why this disagrees:
Selenium supplementation in already-replete individuals may cause metabolic harm. The thyroid benefits must be weighed against potential diabetogenic effects, creating a narrow therapeutic window that complicates broad supplementation recommendations.
Related Claims
Does magnesium supplementation improve sleep quality?
Moderate EvidenceModerate evidence suggests magnesium supplementation may improve sleep quality, particularly in older adults and those with low magnesium intake. Effects include reduced time to fall asleep and improved subjective sleep quality.
Does vitamin D supplementation boost immune function?
Moderate EvidenceModerate-to-good evidence supports vitamin D's role in immune modulation, particularly in reducing respiratory tract infections in deficient individuals. Effects are most pronounced when correcting deficiency rather than supplementing above adequate levels.
Does zinc supplementation boost immune function?
Strong EvidenceStrong evidence shows zinc is essential for immune function and that supplementation reduces cold duration by 1-2 days when taken within 24 hours of symptom onset. Zinc deficiency clearly impairs immunity.